Growth hormone deficiency – Diagnostics – Overview of Information and Clinical Research

Growth hormone deficiency is a rare condition where the body doesn’t produce enough growth hormone, affecting how children grow and how adults maintain their health. Understanding when to seek testing and how doctors diagnose this condition is an important first step toward managing it effectively.

Introduction: Who Should Consider Diagnostic Testing

If you notice that your child is growing much more slowly than other children their age, or if you’re an adult experiencing unexplained fatigue, increased body fat, or decreased muscle strength, it may be time to talk to your doctor about growth hormone deficiency. This condition doesn’t always announce itself loudly, but careful observation can reveal important clues.^[1]

In children, the most obvious warning sign is slow height growth, particularly after the age of three. If a child grows less than about 1.4 inches per year, this can signal a problem with growth hormone production. Children with this condition typically look younger than their peers and may have a chubby body build, an immature-looking face, or delayed tooth development. However, it’s important to know that their intelligence remains completely normal.^[1]^[4]

For adults, the symptoms are quite different but equally important to recognize. You might feel more tired than usual, notice that you’re gaining weight around your waist despite no changes in your habits, or find that you don’t have the strength or stamina you once had. Some adults also experience mood changes, such as feeling anxious, depressed, or isolated from others. These symptoms can overlap with many other conditions, which is why proper diagnostic testing becomes essential.^[6]^[11]

People who have had certain medical treatments are at higher risk and should be especially vigilant. If you’ve had brain surgery, radiation therapy to the head, a severe head injury, or a brain tumor, your doctor may recommend monitoring for growth hormone deficiency even before symptoms appear. Similarly, children born with certain genetic conditions or structural problems with their pituitary gland may need early evaluation.^[2]^[9]

⚠️ Important

Growth hormone deficiency in newborns can sometimes cause low blood sugar levels and exaggerated jaundice in the first days of life. In baby boys, it may also result in a small penis size. If you notice these signs in your newborn, prompt medical evaluation is important to prevent complications and begin appropriate care early.

Classic Diagnostic Methods

Diagnosing growth hormone deficiency requires a careful and methodical approach because growth hormone levels naturally fluctuate throughout the day and night. Your body releases growth hormone in short bursts, mostly during sleep, which makes it very difficult to catch these peaks with a simple blood test taken at a random time. Because of this, doctors use specialized testing methods that go beyond basic blood work.^[5]^[17]

When you first visit your doctor with concerns about growth hormone deficiency, they will begin with a thorough medical history and physical examination. For children, the doctor will carefully measure height, weight, and compare these measurements to standard growth charts for children of the same age and gender. They’ll also look at how fast the child has been growing over time, not just their current height. A child who falls below the third percentile in height for their age might be showing a red flag for growth hormone deficiency.^[4]^[7]

Since direct measurement of growth hormone in the blood is unreliable due to its pulsatile nature, doctors often start by measuring proteins that serve as markers of growth hormone function. These include IGF-1 (insulin-like growth factor 1) and IGFBP-3 (insulin-like growth factor binding protein 3). These proteins are produced in response to growth hormone and remain at more stable levels in the bloodstream, making them easier to measure accurately. Low levels of these proteins can suggest that the body isn’t producing enough growth hormone, though they’re not definitive on their own.^[2]^[7]

The most important diagnostic tools are growth hormone stimulation tests. These tests observe how your pituitary gland responds when it’s provoked to produce growth hormone. During these tests, which are typically done in an outpatient setting and take about two to three hours, you’ll be given a substance that should trigger your pituitary gland to release growth hormone. Common stimulation tests include the insulin tolerance test, the GHRH-arginine stimulation test, and the glucagon stimulation test. You’ll need to fast before the test, and medical staff will draw several blood samples over a period of time to see how your growth hormone levels respond.^[5]^[11]

In addition to blood tests, doctors often order imaging studies to look at the structure of your pituitary gland and the surrounding brain tissue. A magnetic resonance imaging scan (MRI) can reveal whether there are any tumors, structural abnormalities, or damage to the pituitary gland or hypothalamus that might explain why growth hormone production is impaired. This is particularly important if you have a history of head injury, brain surgery, or radiation therapy.^[5]^[17]

For children specifically, doctors may also order a bone age X-ray. This involves taking an X-ray of one of the child’s hands and wrists and comparing it to standard images to determine the child’s skeletal maturity. Children with growth hormone deficiency often have delayed bone development, meaning their bones appear younger than expected for their actual age. This can provide additional evidence to support the diagnosis.^[7]^[10]

It’s important to understand that doctors must rule out other conditions that can cause slow growth or similar symptoms. In children, conditions like hypothyroidism (low thyroid hormone), Turner syndrome, Prader-Willi syndrome, or simply being small for gestational age can all affect growth. In adults, other hormonal imbalances, depression, or chronic illnesses can cause symptoms similar to growth hormone deficiency. Your doctor will likely test for these other possibilities to ensure an accurate diagnosis.^[3]^[9]

Some people with growth hormone deficiency also have deficiencies in other pituitary hormones, a condition called hypopituitarism. Your doctor may test for levels of other important hormones such as thyroid-stimulating hormone, adrenocorticotropic hormone, and sex hormones. Understanding the full picture of your pituitary function helps guide the most appropriate treatment plan.^[1]^[12]

Diagnostics for Clinical Trial Qualification

When researchers design clinical trials to study new treatments for growth hormone deficiency, they need very specific and standardized ways to identify which patients can participate. The diagnostic criteria for enrolling in a clinical trial are often more rigorous than those used in routine clinical practice, ensuring that all study participants truly have the condition being studied and that results can be compared accurately across different study sites.^[10]^[13]

Clinical trials typically require documented evidence of growth hormone deficiency through stimulation testing. Most trials set specific thresholds for what constitutes an inadequate growth hormone response. For example, a trial might require that peak growth hormone levels during stimulation testing fall below a certain value, such as 10 micrograms per liter, to confirm deficiency. These cutoff values are chosen based on scientific evidence and consensus among experts in the field.^[10]

In addition to stimulation tests, clinical trials often mandate measurement of IGF-1 levels. Researchers want to see that IGF-1 is below the normal range for the patient’s age and gender before allowing enrollment. This provides an additional layer of confirmation that growth hormone function is truly impaired. Some trials may also require measurement of IGFBP-3 as further supporting evidence.^[13]

For pediatric clinical trials, detailed growth records are essential. Researchers typically require documented evidence of poor growth velocity over a specific period, often at least six months to one year. They’ll want to see that the child’s height is significantly below average for their age and that their growth rate is slower than expected. Growth charts and regular height measurements become critical pieces of documentation for trial eligibility.^[10]^[13]

Imaging studies are also standard requirements for many clinical trials. An MRI of the brain and pituitary region helps researchers understand whether there are structural causes for the growth hormone deficiency and ensures that participants don’t have conditions that would make the experimental treatment unsafe. For instance, trials might exclude people with active brain tumors or those who recently completed radiation therapy.^[5]

Clinical trials often have additional inclusion and exclusion criteria based on other health factors. Researchers may require normal thyroid function, normal kidney function, and absence of other serious medical conditions. They want to study the effects of the experimental treatment specifically on growth hormone deficiency without the complications of multiple other diseases. Complete blood counts, metabolic panels, and assessments of other pituitary hormones are commonly required as part of the screening process.^[10]

Some trials may also assess baseline bone density using specialized scans, particularly in studies of adults with growth hormone deficiency. Since low growth hormone can affect bone strength, researchers want to document the starting point and track changes over time. Similarly, body composition measurements using techniques like DEXA scans (which measure fat and muscle mass) might be required to establish baseline values before treatment begins.^[20]

⚠️ Important

If you’re considering participating in a clinical trial for growth hormone deficiency, be prepared for a thorough and sometimes lengthy screening process. These extensive requirements aren’t meant to discourage participation but rather to ensure your safety and the scientific validity of the study. The diagnostic tests used for trial qualification also provide you and your doctors with a very complete picture of your health status.

Prognosis and Survival Rate

Prognosis

The outlook for people with growth hormone deficiency is generally very positive when the condition is diagnosed early and treated appropriately. For children, starting growth hormone treatment before puberty gives them the best chance of reaching a normal adult height. Many children who receive early and consistent treatment can catch up significantly in their growth and achieve heights within the normal range for their families. However, if severe growth hormone deficiency is present from birth and never treated, adult heights can be as short as 48 to 65 inches.^[3]^[9]

Beyond height, children with treated growth hormone deficiency typically develop normally in other ways. Their muscle strength improves, their body composition becomes healthier with less excess fat, and their bone density strengthens. The earlier treatment begins, the better these outcomes tend to be. Delayed diagnosis can mean missed opportunities for optimal growth, particularly if treatment doesn’t start until after the child has already gone through puberty, when growth plates in the bones have closed.^[3]^[4]

For adults with growth hormone deficiency, the prognosis also improves substantially with appropriate treatment. While treatment won’t increase height once the growth plates have fused, it can address many of the other symptoms of the condition. Adults who receive growth hormone replacement often experience improved muscle mass and strength, reduced body fat (especially around the waist), better bone density, improved cholesterol levels, and enhanced quality of life with increased energy and improved mood.^[11]^[20]

Some research has indicated that untreated adult growth hormone deficiency may be associated with increased cardiovascular risk factors, decreased bone density leading to higher fracture risk, and reduced quality of life. However, with proper management and monitoring, many of these risks can be reduced. Regular follow-up with your healthcare provider is important to ensure treatment is working effectively and to adjust doses as needed over time.^[4]^[20]

Survival Rate

Growth hormone deficiency itself is not typically life-threatening when properly managed. The condition is treatable, and with appropriate care, people with growth hormone deficiency can live normal, healthy lives. However, some studies have suggested that untreated or inadequately treated adult growth hormone deficiency may be associated with increased mortality rates compared to the general population, possibly related to cardiovascular complications and other metabolic issues.^[20]

It’s important to note that many cases of growth hormone deficiency are caused by underlying conditions such as brain tumors, pituitary damage from surgery or radiation, or severe head injuries. In these situations, the overall prognosis and survival may be more influenced by the underlying cause rather than the growth hormone deficiency itself. Long-term surveillance and comprehensive medical care that addresses all aspects of a person’s health are essential for the best outcomes.^[2]^[12]

#1 Clinical Trials Search in Europe